Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 22, 2026
YAP1 defines an emergent, plastic population of relapsed small cell lung cancerC Allison Stewart, Kavya Ramkumar, Runsheng Wang, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
YAP1 defines an emergent, plastic population of relapsed small cell lung cancerC Allison Stewart, Kavya Ramkumar, Runsheng Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 19, 2020
STING Pathway Expression Identifies NSCLC With an Immune-Responsive PhenotypeCarminia M Della Corte, Triparna Sen, Carl M Gay, et al.
Iscience|March 4, 2025
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancerCaterina De Rosa, Floriana Morgillo, Luisa Amato, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiologyC Allison Stewart, Carl M Gay, Kavya Ramkumar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 18, 2021
Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2-Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 PathophysiologyC Allison Stewart, Carl M Gay, Kavya Ramkumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic VulnerabilitiesC Allison Stewart, Lixia Diao, Yuanxin Xi, et al.
Cancer Cell|January 22, 2021
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M Gay, C Allison Stewart, Elizabeth M Park, et al.
Molecular Cancer|October 31, 2024
Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitorsClare E Murray, Anand V R Kornepati, Carlos Ontiveros, et al.
Cancer Cell|July 11, 2025
KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancerAna Galan-Cobo, Natalie I Vokes, Yu Qian, et al.
Pageof 3